Ni Heyu, Freedman John
Transfusion Medicine Research, Department of Laboratory Medicine and Pathobiology, St. Michael's Hospital, University of Toronto and the Canadian Blood Services, Toronto, Ont.,Canada M5B1W8.
Transfus Apher Sci. 2003 Jun;28(3):257-64. doi: 10.1016/S1473-0502(03)00044-2.
Platelet adhesion and aggregation at the site of vascular injury are two key events in hemostasis and thrombosis. The contribution of several platelet receptors and their ligands has been highlighted in these processes. In platelet adhesion, particularly at high shear stress, GP1b-von Willebrand factor (vWF) interaction may initiate this event, which is followed by firm platelet adhesion mediated by members of the integrin family, such as beta1 (alpha2beta1, alpha5beta1) and beta3 (alphaIIbbeta3) integrins. In platelet aggregation, although GP1b-vWF, P selectin-sulfatides, and other molecules, may play some roles, the process is mainly mediated by beta3 (alphaIIbbeta3) integrin and its ligands, such as fibrinogen and vWF. Recent studies with perfusion chambers and intravital microscopy have revised the dogma established with the static (low shear stress) conditions. It is intriguing that platelet adhesion and aggregation do still occur in mice lacking both vWF and fibrinogen, suggesting that other unexpected molecule(s) may also be important in hemostasis and thrombosis.
血管损伤部位的血小板黏附和聚集是止血和血栓形成过程中的两个关键事件。在这些过程中,几种血小板受体及其配体的作用已得到凸显。在血小板黏附中,尤其是在高剪切应力下,糖蛋白1b(GP1b)-血管性血友病因子(vWF)相互作用可能引发这一事件,随后由整合素家族成员介导血小板牢固黏附,如β1(α2β1、α5β1)和β3(αIIbβ3)整合素。在血小板聚集中,虽然GP1b-vWF、P选择素-硫脂及其他分子可能发挥一些作用,但该过程主要由β3(αIIbβ3)整合素及其配体介导,如纤维蛋白原和vWF。最近利用灌注室和活体显微镜进行的研究修正了在静态(低剪切应力)条件下确立的理论。有趣的是,在同时缺乏vWF和纤维蛋白原的小鼠中仍会发生血小板黏附和聚集,这表明其他意想不到的分子在止血和血栓形成中可能也很重要。